Innovassynth Technologies Q2 & H1 FY27 Financial and Operational Performance
Innovassynth Technologies (India) Ltd 路 Investor Presentation 路 03 Nov 2026, 3:02 am
Innovassynth Technologies Q2 & H1 FY27 Financial and Operational Performance Innovassynth Technologies reported H1 FY27 revenue of INR 10,353 lakhs, surging from INR 2,955 lakhs in H1 FY26, with EBITDA swinging to INR 1,664 lakhs (16% margin) and PAT reaching INR 823 lakhs. For Q2 FY27, revenue reached INR 4,755 lakhs with EBITDA of INR 168 lakhs (4% margin), impacted by sales spillovers into Q3 and higher raw material costs. Total order book stood robust at ~INR 137 crore as of 30th Sep'26, led by Life Sciences (INR ~73 crore) and CDMO (INR ~55 crore). Management expects H2 performance to surpass H1.
Original exchange filing (PDF)
More announcements from Innovassynth Technologies (India) Ltd
- Monitoring Agency report for the quarter ended September 30, 2026. 路 03 Nov 2026
- Reappointment of Dr. Hardik Joshipura as MD & CEO of the Company for a further term of three years commencing from February 12, 2027, to February 11, 2030, subject to approval of the shareholders .... 路 03 Nov 2026
- Financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Outcome of the Board Meeting for the approval of the unaudited financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Innovassynth Technologies (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve the Unaudited .... 路 02 Nov 2026
- Voting Results and Scrutinizer''s Report of the 18th Annual General Meeting of the Company 路 02 Oct 2026
- Proceedings of the 18th Annual General Meeting of the Company. 路 01 Oct 2026
- Annual Report of Innovassynth Technologies (India) Limited ('the Company') for FY 2025-26. 路 08 Sept 2026
